Skip to main content
Top
Published in: Pediatric Nephrology 4/2006

01-04-2006 | Editorial Commentary

Is genetic testing of healthy pre-symptomatic children with possible Alport syndrome ethical?

Authors: Lawrence Copelovitch, Bernard S. Kaplan

Published in: Pediatric Nephrology | Issue 4/2006

Login to get access

Excerpt

“The better part of valor is discretion”
Literature
1.
go back to reference Slajpah M, Meglic A, Furlan P, Glavac D (2005) The importance of non-invasive genetic analysis in the initial diagnosis of Alport syndrome in young patients. Pediatr Nephrol 20:1260–1264CrossRefPubMed Slajpah M, Meglic A, Furlan P, Glavac D (2005) The importance of non-invasive genetic analysis in the initial diagnosis of Alport syndrome in young patients. Pediatr Nephrol 20:1260–1264CrossRefPubMed
2.
go back to reference Nelson RM, Botkjin JR, Kodish ED, Levetown M, Truman JT, Wilfond BS, Harrison CE, Kazura A, Krug E 3rd, Schwartz PA, Donovan GK, Fallat M, Porter IH, Steinberg D (2001) Committee on bioethics. Ethical issues with genetic testing in pediatrics. Pediatrics 107:1451–1455CrossRefPubMed Nelson RM, Botkjin JR, Kodish ED, Levetown M, Truman JT, Wilfond BS, Harrison CE, Kazura A, Krug E 3rd, Schwartz PA, Donovan GK, Fallat M, Porter IH, Steinberg D (2001) Committee on bioethics. Ethical issues with genetic testing in pediatrics. Pediatrics 107:1451–1455CrossRefPubMed
3.
go back to reference Ravine DL, Walker RG, Gibson RN, Forrest SM, Richards RI, Friend K, Sheffield LJ, Kincaid-Smith P, Danks DM (1992) Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease. Lancet 340:1330–1333CrossRefPubMed Ravine DL, Walker RG, Gibson RN, Forrest SM, Richards RI, Friend K, Sheffield LJ, Kincaid-Smith P, Danks DM (1992) Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease. Lancet 340:1330–1333CrossRefPubMed
4.
go back to reference Marsick R, Limwongse C, Kodish E (1998) Genetic testing for renal diseases: medical and ethical considerations. Am J Kidney Dis 32:943–945 Marsick R, Limwongse C, Kodish E (1998) Genetic testing for renal diseases: medical and ethical considerations. Am J Kidney Dis 32:943–945
5.
go back to reference Anonymous (1995) Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Society of Human Genetics Board of Directors; American College of Medical Genetics Board of Directors. Am J Hum Genet 57:1233–1241 Anonymous (1995) Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Society of Human Genetics Board of Directors; American College of Medical Genetics Board of Directors. Am J Hum Genet 57:1233–1241
6.
go back to reference Chapman MA (1992) Canadian experience with predictive testing of Huntington disease: lessons for genetic testing centers and policy makers. Am J Med Genetics 42:491–498CrossRef Chapman MA (1992) Canadian experience with predictive testing of Huntington disease: lessons for genetic testing centers and policy makers. Am J Med Genetics 42:491–498CrossRef
7.
go back to reference Wexler N (1992) The Tiresias complex: Huntington’s disease as a paradigm of testing for late-onset disorders. FASEB J 6:2820–2825PubMed Wexler N (1992) The Tiresias complex: Huntington’s disease as a paradigm of testing for late-onset disorders. FASEB J 6:2820–2825PubMed
8.
go back to reference Jais JP, Kenebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Nezter KO, Flinter F, Pirson Y, Verellen C, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schroder C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2000) X-linked Alport syndrome: natural history in 195 families and genotype–phenotype correlations in males. J Am Soc Nephrol 11:649–657PubMed Jais JP, Kenebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Nezter KO, Flinter F, Pirson Y, Verellen C, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schroder C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2000) X-linked Alport syndrome: natural history in 195 families and genotype–phenotype correlations in males. J Am Soc Nephrol 11:649–657PubMed
9.
go back to reference Gross O, Netzer KO, Lambrect R, Seibold S, Weber M (2002) Meta-analysis of genotype–phenotype correlation in X-linked Alport syndrome: impact on clinical counseling. Nephrol Dial Transplant 17:1218–1227CrossRefPubMed Gross O, Netzer KO, Lambrect R, Seibold S, Weber M (2002) Meta-analysis of genotype–phenotype correlation in X-linked Alport syndrome: impact on clinical counseling. Nephrol Dial Transplant 17:1218–1227CrossRefPubMed
10.
go back to reference Feld LG, Meyers KE, Kaplan BS, Stapleton FB (1998) Limited evaluation of microscopic hematuria in pediatrics. Pediatrics 102:E42CrossRefPubMed Feld LG, Meyers KE, Kaplan BS, Stapleton FB (1998) Limited evaluation of microscopic hematuria in pediatrics. Pediatrics 102:E42CrossRefPubMed
11.
go back to reference Bergstein J, Leiser J, Andreoli S (2005) The clinical significance of asymptomatic gross and microscopic hematuria in children. Arch Pediatr Adolesc Med 159:353–355CrossRefPubMed Bergstein J, Leiser J, Andreoli S (2005) The clinical significance of asymptomatic gross and microscopic hematuria in children. Arch Pediatr Adolesc Med 159:353–355CrossRefPubMed
12.
go back to reference Diven SC, Travis LB (2000) A practical primary care approach to hematuria in children. Pediatr Nephrol 14:65–72CrossRefPubMed Diven SC, Travis LB (2000) A practical primary care approach to hematuria in children. Pediatr Nephrol 14:65–72CrossRefPubMed
13.
go back to reference Rana K, Wang YY, Powell H, Jones C, McCreie D, Buzza M, Udawela M, Savige J (2005) Persistent familial hematuria in children and the locusfor thin basement membrane nephropathy. Pediatr Nephrol 20:1729-1737PubMedCrossRef Rana K, Wang YY, Powell H, Jones C, McCreie D, Buzza M, Udawela M, Savige J (2005) Persistent familial hematuria in children and the locusfor thin basement membrane nephropathy. Pediatr Nephrol 20:1729-1737PubMedCrossRef
Metadata
Title
Is genetic testing of healthy pre-symptomatic children with possible Alport syndrome ethical?
Authors
Lawrence Copelovitch
Bernard S. Kaplan
Publication date
01-04-2006
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 4/2006
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-005-0003-4

Other articles of this Issue 4/2006

Pediatric Nephrology 4/2006 Go to the issue